| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/16/1999 | US5872299 Method of preparing intermediates for retroviral protease inhibitors |
| 02/16/1999 | US5872298 Method of preparing intermediates for retroviral protease inhibitors |
| 02/16/1999 | US5872280 Respiratory system disorders |
| 02/16/1999 | US5872242 Antisense oligonucleotide inhibition of ras |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872217 Antibodies which specifically bind a cancer related antigen |
| 02/16/1999 | US5872151 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 02/16/1999 | US5872150 Treatment of prostate disease with a nonsteroidal anti-androgenic compound |
| 02/16/1999 | US5872149 Alk(en)yldicarboxylic acid bisesters, their use, and processes for their preparation |
| 02/16/1999 | US5872147 Use of oxandrolone in the treatment of chronic obstructive pulmonary disease |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872145 Formulation of 5-HT agonist and NSAID for treatment of migraine |
| 02/16/1999 | US5872142 1,3-dioxane or -dioxolane derivatives of 1h-1,2,4-triazole |
| 02/16/1999 | US5872141 Method of inhibiting cholesterol transport |
| 02/16/1999 | US5872140 Vitamin D analogues |
| 02/16/1999 | US5872135 Enzyme inhibitors |
| 02/16/1999 | US5872134 Antiarrthmia, stroke, central nervous systems, schizophrenia |
| 02/16/1999 | US5872133 Method of regulating the immune response |
| 02/16/1999 | US5872131 Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives |
| 02/16/1999 | US5872130 Quinoline type mevalonoactones |
| 02/16/1999 | US5872129 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
| 02/16/1999 | US5872128 Stabilized composition of ticlopidine hydrochloride |
| 02/16/1999 | US5872127 Method of regulating immune function |
| 02/16/1999 | US5872126 Enzyme inhibitors for treatment of premature labor |
| 02/16/1999 | US5872125 Polymorphs of lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it |
| 02/16/1999 | US5872124 Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite |
| 02/16/1999 | US5872123 Administering granciclovir, valcyclovir, famcyclovir, cidofovir, and pharmaceutically acceptable derivatives and mixtures thereof. |
| 02/16/1999 | US5872120 Apoptosis regulating composition |
| 02/16/1999 | US5872119 2-Naphthamide derivatives and their therapeutic applications |
| 02/16/1999 | US5872118 Relaxation of skeletal muscle in spastic, hypertonic and hyperkinetic conditions |
| 02/16/1999 | US5872115 Compounds for treatment of hypercholesterolemia, ischemic heart disease, cerebrovascular disease or atherosclerosis |
| 02/16/1999 | US5872114 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/16/1999 | US5872112 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 02/16/1999 | US5872111 Compositions comprising glycosylamide surfactants |
| 02/16/1999 | US5872110 Heparin-like derivatives |
| 02/16/1999 | US5872109 Anti-inflammatory agent |
| 02/16/1999 | US5872108 Protecting brain tissue from cerebral infarction subsequent to ischemia |
| 02/16/1999 | US5872107 Anticarcinogenic agents capture therapy for tumors |
| 02/16/1999 | US5872106 Antimessenger oligonucleotide against urokinase receptor |
| 02/16/1999 | US5872103 Prevention of mammary tumors by treatment with cardiac glycosides |
| 02/16/1999 | US5872096 Modified sialyl Lewisa compounds |
| 02/16/1999 | US5872007 CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871954 Acylation of peptide or protein by reacting with coenzyme a ester of an oxy- or thio-substituted fatty acid analog in presence of n-myristoyl transferase |
| 02/16/1999 | US5871950 Methods of treating autoimmune diseases and transplantation rejection |
| 02/16/1999 | US5871900 Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens |
| 02/16/1999 | US5871799 Foods and beverages having decreased digestive and absorptive properties |
| 02/16/1999 | US5871779 Treatment of arthropathies with vanadate compounds or analogues thereof |
| 02/16/1999 | US5871778 Sustained release microsphere preparation containing antipsychotic drug |
| 02/16/1999 | US5871776 Controlled-release nifedipine |
| 02/16/1999 | US5871775 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 02/16/1999 | US5871774 Drug units and methods for use |
| 02/16/1999 | US5871772 Sodium hyaluronate viscous solutions for use as masking fluid in therapeutic photokeratectomy by means of excimer laser |
| 02/16/1999 | US5871771 Micronized biodegradable particles, process for preparing them and use thereof |
| 02/16/1999 | US5871769 Using magnesium gluconate alone or in combination with antioxidants selected from vitamin e, selenium, glutathione, isopropyl glutathionate and n-acetylcysteine; prevention of oxygen free radical and lipid peroxidation production |
| 02/16/1999 | US5871766 Beta-carotene vitamin E therapy for inhibition of major vascular events |
| 02/16/1999 | US5871755 Dehydroalanine derivatives for protecting the skin, the mucous membranes and/or the hair from oxidative stress, cosmetic or dermatological compositions containing them |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871740 Genetic engineering with proteins, antiinflammatory agents and gene expression |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | US5871709 Tetraazacyclododecane compounds substituted with alkyl carboxy compounds for cardiovascular disorders and brain tumors |
| 02/16/1999 | US5871472 To preselected brain areas |
| 02/16/1999 | CA2162329C Novel solar screens, cosmetic ultraviolet-protecting compositions containing the same and their use |
| 02/16/1999 | CA2104733C Urea/lactate topical compositions for dry skin |
| 02/16/1999 | CA2083386C Phosphorous prodrugs |
| 02/16/1999 | CA2066192C Radiation synovectomy compositions |
| 02/16/1999 | CA2021576C Agent for preventing and treating opacity of lens |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/16/1999 | CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2244797A1 Droloxifene for prevention of breast cancer |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/12/1999 | CA2231728A1 Mray |
| 02/11/1999 | WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006438A2 Compounds with anti-ks and anti-hiv activity |
| 02/11/1999 | WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | WO1999006424A1 Lyxofuranosyl benzimidazoles as antiviral agents |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006422A2 Base analogues |
| 02/11/1999 | WO1999006421A1 Synthetic insulin mimetic substances |
| 02/11/1999 | WO1999006410A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | WO1999006409A1 Tricyclic vasopressin agonists |
| 02/11/1999 | WO1999006408A1 New 2,3-benzodiazepine derivatives |
| 02/11/1999 | WO1999006407A1 THERAPEUTICALLY ACTIVE 1,2,4-TRIAZOLO(4.,3-b) PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS |
| 02/11/1999 | WO1999006406A1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]-INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY |
| 02/11/1999 | WO1999006404A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | WO1999006403A1 Tricyclic vasopressin agonists |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006395A1 Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase |